REG - Futura Medical PLC - Notice of Interim Results <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

19/08/2015 07:01

RNS Number : 4080W
Futura Medical PLC
19 August 2015
For immediate release
19 August 2015
Futura Medical plc
("Futura" or the "Company")
Notice of Interim Results
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2015 on Wednesday 9 September 2015. 
A briefing for analysts will be held at 9.30am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN. 
There will be a live webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 9.30am on the day of results: 
http://vm.buchanan.uk.com/2015/futuramedical090915/registration.htm
A recording of the webcast will also be made available at www.futuramedical.com and www.buchanan.uk.com, following the results meeting. 
For more information, or to register attendance, please contact Buchanan on 020 7466 5000.
For further information please contact:
Futura Medical plc

James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
Email to: james.barder@futuramedical.com
www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Tom Smale - Corporate Finance 
Tel:+44 (0) 20 7496 3000
For media enquiries please contact: 

Buchanan 

Mark Court / Sophie Cowles / Stephanie Watson
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NORSFAFIAFISEFA